Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of virtual reality-based balance training in multiple sclerosis.
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
AMPYRA® two-year safety data presented at 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Do people with and without medical conditions respond similarly to the Short Health Anxiety Inventory? An assessment of differential item functioning using item response theory.
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system.
G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
Pain mechanisms in multiple sclerosis.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it's time!
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Remyelination after Lysophosphatidyl Choline-Induced Demyelination Is Stimulated by Bone Marrow Stromal Cell-Derived Oligoprogenitor Cell Transplantation.
Future MS care: a consensus statement of the MS in the 21st Century Steering Group.
B-cell-directed therapy: which B cells should be targeted and how?
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity.
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Immune-Reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
Evidence for a two-stage disability progression in multiple sclerosis.
Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4.

Pages